| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 86780VJI1Q |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Receptor tyrosine-protein kinase erbB-3 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Carcinoma | 1 | D002277 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109396 |
| FDA SRS | 86780VJI1Q |
CONTENTS